A citation-based method for searching scientific literature

Nikki Peters, Susan M Domchek, Abigail Rose, Rachael Polis, Jill Stopfer, Katrina Armstrong. Genet Test 2005
Times Cited: 39







List of co-cited articles
180 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
281
28


The association between race and attitudes about predictive genetic testing.
Nikki Peters, Abigail Rose, Katrina Armstrong. Cancer Epidemiol Biomarkers Prev 2004
88
23

Attitudes and misconceptions about predictive genetic testing for cancer risk.
Abigail L Rose, Nikki Peters, Judy A Shea, Katrina Armstrong. Community Genet 2005
33
21

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
598
15

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
116
15

The role of financial factors in acceptance of clinical BRCA genetic testing.
Shannon Kieran, Lois J Loescher, Kyung Hee Lim. Genet Test 2007
32
18


Racial and ethnic variations in knowledge and attitudes about genetic testing.
Eleanor Singer, Toni Antonucci, John Van Hoewyk. Genet Test 2004
120
15

Referral and experience with genetic testing among women with early onset breast cancer.
Karen L Brown, Robin Hutchison, Randi E Zinberg, Margaret M McGovern. Genet Test 2005
27
22

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
12

Uptake rates for breast cancer genetic testing: a systematic review.
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
112
12

Factors associated with decisions about clinical BRCA1/2 testing.
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
102
12

The association between knowledge and attitudes about genetic testing for cancer risk in the United States.
Abigail Rose, Nikki Peters, Judy A Shea, Katrina Armstrong. J Health Commun 2005
50
12

Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
61
12

Interest in BRCA1/2 testing in a primary care population.
Katrina Armstrong, Barbara Weber, Peter A Ubel, Carmen Guerra, J Sanford Schwartz. Prev Med 2002
53
12

Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
163
12

Genetic testing in young women with breast cancer: results from a Web-based survey.
K J Ruddy, S Gelber, J Shin, J E Garber, R Rosenberg, M Przypysny, A H Partridge. Ann Oncol 2010
17
29

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
10


Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
183
10

Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
425
10

Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis.
Jeffrey N Weitzel, Sarah M McCaffrey, Raluca Nedelcu, Deborah J MacDonald, Kathleen R Blazer, Carey A Cullinane. Arch Surg 2003
116
10

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
91
10

Disparities in genetic testing: thinking outside the BRCA box.
Michael J Hall, Olufunmilayo I Olopade. J Clin Oncol 2006
116
10

What women with ovarian cancer think and know about genetic testing.
Robin A Lacour, Molly S Daniels, Shannon N Westin, Larissa A Meyer, Catherine C Burke, Kimberly A Burns, Shiney Kurian, Nicki F Webb, Terri B Pustilnik, Karen H Lu. Gynecol Oncol 2008
48
10


Confronting genetic testing disparities: knowledge is power.
Michael Hall, Olufunmilayo I Olopade. JAMA 2005
63
10

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
10


Racial and ethnic disparities in awareness of genetic testing for cancer risk.
José A Pagán, Dejun Su, Lifeng Li, Katrina Armstrong, David A Asch. Am J Prev Med 2009
65
10

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
625
10


Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Michael J Green, Susan K Peterson, Maria Wagner Baker, Gregory R Harper, Lois C Friedman, Wendy S Rubinstein, David T Mauger. JAMA 2004
216
7

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
270
7

Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.
Emily A Peterson, Kara J Milliron, Karen E Lewis, Susan D Goold, Sofia D Merajver. Cancer Epidemiol Biomarkers Prev 2002
92
7

Factors influencing patients' decisions to decline cancer genetic counseling services.
K P Geer, M E Ropka, W F Cohn, S M Jones, S Miesfeldt. J Genet Couns 2001
60
7

Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.
Litanja Lodder, Petra G Frets, R Willem Trijsburg, Jan G M Klijn, Caroline Seynaeve, Madeleine M A Tilanus, Carina C M Bartels, E Johanna Meijers-Heijboer, Leon C Verhoog, Martinus F Niermeijer. Am J Med Genet A 2003
25
12

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
Sining Chen, Edwin S Iversen, Tara Friebel, Dianne Finkelstein, Barbara L Weber, Andrea Eisen, Leif E Peterson, Joellen M Schildkraut, Claudine Isaacs, Beth N Peshkin,[...]. J Clin Oncol 2006
218
7

Attitudes to genetic testing for breast cancer susceptibility in women at increased risk developing hereditary breast cancer.
B Meiser, P Butow, A Barratt, G Suthers, M Smith, A Colley, E Thompson, K Tucker. J Med Genet 2000
45
7

A survey of patients' experiences with the cancer genetic counseling process: recommendations for cancer genetics programs.
Dana T Kausmeyer, Eugene J Lengerich, Brenda C Kluhsman, Dorothy Morrone, Gregory R Harper, Maria J Baker. J Genet Couns 2006
26
11

Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
105
7



Information seeking and intentions to have genetic testing for hereditary cancers in rural and Appalachian Kentuckians.
Kimberly M Kelly, James E Andrews, Donald O Case, Suzanne L Allard, J David Johnson. J Rural Health 2007
17
17

Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer.
Donald W Hadley, Jean Jenkins, Eileen Dimond, Kenneth Nakahara, Liam Grogan, David J Liewehr, Seth M Steinberg, Ilan Kirsch. Arch Intern Med 2003
119
7



Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.
Sharon L Manne, Daniel C Chung, David S Weinberg, Hetal S Vig, Zohra Catts, Melissa Klein Cabral, Kristen Shannon, Neal J Meropol. Cancer Epidemiol Biomarkers Prev 2007
18
16

Public attitudes toward genetic testing: perceived benefits and objections.
Lidewij Henneman, Danielle R M Timmermans, Gerrit Van Der Wal. Genet Test 2006
48
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.